Maria J Moreno-Aliaga
Overview
Explore the profile of Maria J Moreno-Aliaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valdecantos M, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, et al.
Nat Commun
. 2024 Nov;
15(1):10342.
PMID: 39609390
Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here...
2.
Yang J, Felix-Soriano E, Martinez-Gayo A, Ibanez-Santos J, Sainz N, Martinez J, et al.
J Physiol Biochem
. 2024 Sep;
80(3):697-712.
PMID: 39264516
Sirtuins 1 (SIRT1) and Forkhead box protein O1 (FOXO1) expression have been associated with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Exercise and/or docosahexaenoic acid (DHA) supplementation have shown...
3.
Burgos M, Gil-Iturbe E, Idoate-Bayon A, Castilla-Madrigal R, Moreno-Aliaga M, Lostao M
J Physiol Biochem
. 2024 May;
PMID: 38727993
Obesity constitutes a global health epidemic which worsens the main leading death causes such as type 2 diabetes, cardiovascular diseases, and cancer. Changes in the metabolism in patients with obesity...
4.
Garcia-Perea A, Fernandez-Cruz E, de la O-Pascual V, Gonzalez-Zorzano E, Moreno-Aliaga M, Tur J, et al.
Medicina (Kaunas)
. 2024 Apr;
60(4).
PMID: 38674256
Modern classification and categorization of individuals' health requires personalized variables such as nutrition, physical activity, lifestyle, and medical data through advanced analysis and clustering methods involving machine learning tools. The...
5.
Martinez-Fernandez L, Burgos M, Sainz N, Laiglesia L, Arbones-Mainar J, Gonzalez-Muniesa P, et al.
Biomolecules
. 2023 Jun;
13(6).
PMID: 37371501
This study analyses the effects of Maresin 1 (MaR1), a docosahexaenoic acid (DHA)-derived specialized proresolving lipid mediator with anti-inflammatory and insulin-sensitizing actions, on the expression of adipokines, including adiponectin, leptin,...
6.
Laiglesia L, Escote X, Sainz N, Felix-Soriano E, Santamaria E, Collantes M, et al.
Mol Metab
. 2023 Jun;
74:101749.
PMID: 37271337
Objective: Maresin 1 (MaR1) is a docosahexaenoic acid-derived proresolving lipid mediator with insulin-sensitizing and anti-steatosis properties. Here, we aim to unravel MaR1 actions on brown adipose tissue (BAT) activation and...
7.
Felix-Soriano E, Sainz N, Gil-Iturbe E, Castilla-Madrigal R, Celay J, Fernandez-Galilea M, et al.
J Physiol Biochem
. 2023 May;
79(2):451-465.
PMID: 37204588
Obesity exacerbates aging-induced adipose tissue dysfunction. This study aimed to investigate the effects of long-term exercise on inguinal white adipose tissue (iWAT) and interscapular brown adipose tissue (iBAT) of aged...
8.
Martinez-Gayo A, Felix-Soriano E, Sainz N, Gonzalez-Muniesa P, Moreno-Aliaga M
Nutrients
. 2022 Oct;
14(20).
PMID: 36296923
Obesity and aging promote chronic low-grade systemic inflammation. The aim of the study was to analyze the effects of long-term physical exercise and/or omega-3 fatty acid Docosahexaenoic acid (DHA) supplementation...
9.
Felix-Soriano E, Sainz N, Fernandez-Galilea M, Gil-Iturbe E, Celay J, Martinez-Climent J, et al.
J Nutr Biochem
. 2022 Sep;
111:109153.
PMID: 36150680
This study aimed to characterize the potential beneficial effects of chronic docosahexaenoic acid (DHA) supplementation on restoring subcutaneous white adipose tissue (scWAT) plasticity in obese aged female mice. Two-month-old female...
10.
Barahona I, Rada P, Calero-Perez S, Grillo-Risco R, Pereira L, Soler-Vazquez M, et al.
Cell Death Differ
. 2022 Jun;
29(12):2362-2380.
PMID: 35681014
Activation of oval cells (OCs) has been related to hepatocyte injury during chronic liver diseases including non-alcoholic fatty liver disease (NAFLD). However, OCs plasticity can be affected under pathological environments....